Demand Analysis of U.S. Cancer Sample Prep Market

Sample prep automation for tumor specimens facilitates future molecular cancer tests

Share this:

This analysis of the U.S. formalin fixed paraffin embedded (FFPE) sample prep market illuminates how the existing FFPE legacy in solid-tumor diagnostics is being transformed by advanced molecular techniques. Customer demand data collected by Frost & Sullivan provides the foundation for a market penetration model in which the relative growth stage of both the hospital and reference lab segments is determined. Furthermore, the adoption trend for FFPE sample prep automation is predicted by an install base forecast in clinical laboratories for 2011 to 2016. Companies that participate in the market include Qiagen, Life Technologies, and Roche Applied Sciences.

Click headings to expand and collapse Author: Winny Tan | 17 Nov 2011

1. Executive Summary
- Market Overview
  - Introduction
2. U.S. Cancer Sample Prep Market
- Market Overview
- Industry Challenges and Strategic Recommendations
  - Industry Challenges
  - Strategic Recommendations
- Market Drivers and Restraints
  - Market Drivers
  - Market Restraints
- Demand Analysis
- Revenue Forecast
  - Revenue Forecast Assumptions
  - Revenue Forecast Analysis
- Competitive Structure
  - Competitive Structure
- Product Analysis
  - Product Analysis
  - Voice-of-Customer Analysis
3. Appendix
- Supplementary Data

Search this document

Tools

Features of this research

Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America

tel: +1.877.463.7678

myfrost@frost.com

Select a location near you..

Demand Analysis of U.S. Cancer Sample Prep Market

Tools

Features of this research

Help Desk

Tag this research

Tag this research